Pharmacists in Calabasas, California


29 Pharmacists found in Calabasas
female pharmacist

Linda Lin


Pharmacist
26521 Agoura Rd, Calabasas, CA 91302
818-880-8692     818-880-8927

female pharmacist

Mera Zakhary


Pharmacist
26521 Agoura Rd, Calabasas, CA 91302
818-880-8807    

female pharmacist

Michelle My Tran, PHARMD


Pharmacist
4766 Park Granada Ste 112, Calabasas, CA 91302
818-963-7525    



female pharmacist

Dr. Mona Ligvani, PHARM.D.


Pharmacist
22277 Mulholland Hwy, Calabasas, CA 91302
818-223-8656    

female pharmacist

Nataliya Bulba


Pharmacist
5544 Las Virgenes Road 107, Calabasas, CA 91302
818-862-8759    

female pharmacist

Mrs. Noushin Saghizadeh, PHARM. D.


Pharmacist
4710 Commons Way, Calabasas, CA 91302
818-222-0549    

male pharmacist

Dr. Peter S Golenia, PHARM.D.


Pharmacist - Pharmacotherapy
4651 Camino Del Sol, Calabasas, CA 91302
702-280-7544    

female pharmacist

Shermineh Vafakhah


Pharmacist
5514 Las Virgenes Rd, Calabasas, CA 91302
818-585-2029    

female pharmacist

Sydney Martinelli



5941 Ruthwood Dr, Calabasas, CA 91302
818-223-1226    

female pharmacist

Tea Janjulia


Pharmacist
26500 Agoura Rd, Calabasas, CA 91302
818-880-8816    

female pharmacist

Mrs. Valerie Anne Mesaros, PHARM D


Pharmacist
26830 Hot Springs Pl, Calabasas, CA 91301
818-914-6085    

female pharmacist

Youlia Galenko


Pharmacist
26500 Agoura Rd Ste 111, Calabasas, CA 91302
818-880-8816     818-880-8891

female pharmacist

Zohreh T Farahbakhsh, RPH, PH.D


Pharmacist
4710 Commons Way, Calabasas, CA 91302
818-222-0549     818-222-0665


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.